Search results
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 23 hours agoIn the past six months, shares of MRNA have rallied 108.94%. (See the last biotech stock roundup...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks· 1 day agoFree Report) and Pfizer (PFE Quick QuotePFE - Free Report) to set up a possible vaccine program aimed at preventing the spread of the H5N1 virus, also known as bird flu, in humans. Both these ...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 4 days agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna and Pfizer In Talks With U.S. To Make a Bird Flu Vaccine
Barrons.com· 2 days agoThe stock, however, keeps going up. Moderna shares have climbed 20% just this week, and 45% since...
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.51% By Investing.com
Investing.com· 2 days agoU.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.51%
European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech
Benzinga via Yahoo Finance· 7 days agoModerna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 4 days agoAll this pulled up the stock price. The acquisition of Harpoon Therapeutics added its lead pipeline...
Cartesian (RNAC) Up as FDA Grants RMAT Tag to Descartes-08
Zacks via Yahoo Finance· 24 hours agoImage Source: Zacks Investment Research Descartes-08 is an autologous anti-B cell maturation antigen...
Arcturus Therapeutics’ (ARCT) Outperform Rating Reaffirmed at William Blair
ETF DAILY NEWS· 10 hours agoARCT has been the topic of a number of other research reports. Canaccord Genuity Group lowered their target price on shares of Arcturus Therapeutics from $87.00 to $86.00 and set a buy rating ...
StageZero Life Sciences Announces Update on Failure to File Cease Trade Order
Digital Journal· 19 hours agoAristotle® uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform...laboratory in Richmond ...